A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Clinical trial NCT03183934 · COMPLETED

Trial details

NCT number: NCT03183934
Sponsor: Anterogen Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Dystrophic Epidermolysis Bullosa

Start date: 2017-12-08
Primary completion: 2018-04-20
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.